Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer

By sjmartinez • April 13, 2023

Nimgaonkar V, Krishna V, Krishna V, Tiu E, Joshi A, Vrabac D, Bhambhvani H, Smith K, Johansen JS, Makawita S, Musher B, Mehta A, Hendifar A, Wainberg Z, Sohal D, Fountzilas C, Singhi A, Rajpurkar P, Collisson EA. Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Cell Rep Med. 2023 Apr 5:101013. doi: 10.1016/j.xcrm.2023.101013. Epub ahead of print. PMID: 37044094.

Tags: digital pathology, Hematology/Oncology, pancreatic cancer, Predictive biomarker, Publications

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia

O'Connor TE, Lin C, Roloff GW, Zhang A, Miller K, Aldoss I, Kopmar NE, Dekker SE, Gupta VK, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed[...]

Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient

Eeraveni A, Gates G, Singh A, Ahronowitz I. Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient. Cureus. 2025 Jul 21;17(7):e88451. doi: 10.7759/cureus.88451.[...]

Intermediate endpoints as surrogates for long term outcomes in breast cancer adjuvant chemotherapy trials

Blasco A, López-Tarruella S, Urruticoechea A, Carrasco E, Spera G, Martín M, Bermejo B, Chap L, Ruiz-Borrego M, Crown J, García-Saenz JA, Chan A, Guerrero-Zotano[...]